Form 4: Saul Centers Inc. Executive Acquires Shares and Performance Shares
SEC Form 4
John F. Collich, Sr. VP, Chief Acq. & Dev. Off. of Saul Centers, Inc., reports acquisition of common stock and performance shares, along with dividend reinvestments.
Summary
- On March 6, 2025, John F. Collich, Sr. VP, Chief Acq. & Dev. Off. of Saul Centers, Inc., filed a Form 4.
- The filing reports the acquisition of 300 restricted shares of common stock and 150 additional restricted shares of common stock earned based on performance criteria.
- These shares vest on May 17, 2029, assuming continued employment.
- Collich also acquired shares through dividend reinvestment plans for himself and his wife's accounts.
- The total direct holdings of common stock are now 43,380 shares.
- He also holds options to purchase 20,000 shares each, vesting over four years from the grant dates between 2015 and 2023.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions and doesn't inherently indicate positive or negative sentiment about the company's future performance. The acquisition of performance shares suggests achievement of some performance criteria.
Positives
- The acquisition of performance shares suggests the achievement of certain performance criteria, which could be viewed positively.
- Continued participation in the Dividend Reinvestment Plan indicates a long-term investment perspective.
Risks
- The vesting of restricted shares is contingent upon continued employment, creating a potential risk if employment is terminated before May 17, 2029.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking to understand management's view of the company's prospects.
Stakeholder Impact
- The transactions reported in the Form 4 may have a minor impact on shareholders by slightly increasing the number of outstanding shares.
- The vesting of restricted shares incentivizes the executive to remain with the company, potentially benefiting employees and other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 05/08/2015 | Date of grant for employee stock option with exercise price of $51.07, expiring on 05/08/2025 |
| 05/06/2016 | Date of grant for employee stock option with exercise price of $57.74, expiring on 05/06/2026 |
| 05/05/2017 | Date of grant for employee stock option with exercise price of $59.41, expiring on 05/05/2027 |
| 05/11/2018 | Date of grant for employee stock option with exercise price of $49.46, expiring on 05/11/2028 |
| 05/03/2019 | Date of grant for employee stock option with exercise price of $55.71, expiring on 05/03/2029 |
| 04/24/2020 | Date of grant for employee stock option with exercise price of $50, expiring on 04/24/2030 |
| 05/07/2021 | Date of grant for employee stock option with exercise price of $43.89, expiring on 05/07/2031 |
| 05/13/2022 | Date of grant for employee stock option with exercise price of $47.9, expiring on 05/13/2032 |
| 05/12/2023 | Date of grant for employee stock option with exercise price of $33.79, expiring on 05/12/2033 |
| 07/31/2024 | Date of dividend reinvestment plan award |
| 10/31/2024 | Date of dividend reinvestment plan award |
| 01/31/2025 | Date of dividend reinvestment plan award |
| 03/06/2025 | Date of transaction for acquisition of restricted shares and performance shares |
| 03/10/2025 | Date of signature on the Form 4 |
| 05/17/2029 | Vesting date for restricted shares and performance shares |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.